NIO Inc. vs Regeneron Pharmaceuticals Inc — how do they compare? NIO Inc. trades at $4.81 (market cap $12.55B), while Regeneron Pharmaceuticals Inc trades at $670 (market cap $70.47B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 5.6× NIO Inc.'s market cap, and Regeneron Pharmaceuticals Inc pays a 0.56% dividend while NIO Inc. pays none. Which is the better fit depends on your goals.
| NIO | REGN | |
|---|---|---|
Market Cap | $12.55B | $70.47B |
Sector | Consumer Cyclical | Health |
52-Week High | $7.89 | $812.27 |
52-Week Low | $4.44 | $545.46 |
Enterprise Value | $11.78B | $64.42B |
Dividend Yield | — | 0.56% |
Trailing returns across standard periods
Latest headlines on both assets
NIO Inc. manufactures and sells automobiles. The Company offers electric vehicles and parts, as well as provides battery charging services. NIO serves customers worldwide.
Read more on NIO →Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →